Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07117695 · ClinicalTrials.gov registry record · NA
Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors
A NA study, sponsored by Duke University.
- Not yet
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT07117695 is a NA study that has not yet begun recruiting, run by Duke University. The registered enrollment target is 150 participants.
The verdict
NCT07117695, a NA study, has not yet begun recruiting, sponsored by Duke University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
This project is studying whether a team-based specialty clinic can help people with type 2 diabetes and heart disease better manage their blood pressure and cholesterol. The clinic includes coordinated care from heart doctors, kidney doctors, diabetes specialists, and liver doctors. The study will compare two groups of patients: one receiving usual care from their primary care provider, and one referred to the Duke Cardiometabolic Prevention Clinic for multidisciplinary care. The main goals are to find out if this clinic improves blood pressure and cholesterol control over 12 months, increases use of recommended heart medications, and reduces hospital visits and other healthcare use. Participants will be randomly assigned to one of the two groups. Those referred to the clinic will: 1) Meet with a cardiologist for an initial evaluation. 2) Be referred to other specialists (such as endocrinology, nephrology, or hepatology) based on their needs. 3) Receive ongoing, coordinated care from a team of specialists working together to improve their heart and metabolic health.
Interventions
- OTHER Referral to the Duke Cardiometabolic Prevention Clinic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-06-02 |
| Est. Completion | 2027-12-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07117695
The ClinicalTrials.gov registry entry for NCT07117695 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Referral to the Duke Cardiometabolic Prevention Clinic is the first listed.
NCT07117695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07117695 about?
NCT07117695 is a clinical study titled "Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors". This project is studying whether a team-based specialty clinic can help people with type 2 diabetes and heart disease better manage their blood pressure and cholesterol. The clinic includes coordinated care from heart doctors, kidney doctors, diabetes specialists, and liver doctors. The study will ...
What is the current status of trial NCT07117695?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-06-02. Estimated completion is 2027-12-27.
What interventions are being tested in trial NCT07117695?
The interventions under investigation include: Referral to the Duke Cardiometabolic Prevention Clinic (OTHER).
Who is sponsoring clinical trial NCT07117695?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.